-
If you purchased shares of Hospira, Inc. (NYSE HSP), and / or if you have any information relating the investigation including those who are former employees or/and whistleblowers, you may have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
San Diego, Nov. 11, 2011 (Shareholders Foundation) -- An investigation on behalf of investors in shares of Hospira, Inc. (NYSE: HSP) over possible Violations of Federal Securities Laws was announced.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Hospira (NYSE:HSP) concerning whether the company, certain of its officers and directors, or others have possibly violated federal securities laws. Specifically, the investigation concerns whether certain statements regarding Hospiras business, its prospects and its operations were potentially materially false and misleading at the time they were made.
While Hospiras annual Revenue rose from $3.87billion in 2009 to $3.91billion in 2010, its Net Income fell from $403.90million in 09 to $357.20million in 2010. Its second quarter Revenue rose from $949.30million last year to $976.70million this year, but its Net Income fell from a second quarter 2010 Net Income of $71.40million to a second quarter 2011 Net Loss of $88.90million.
Shares of Hospira, Inc. (Public, NYSE:HSP) rose from as low as $22.21 in March 09 to as high as almost $60 per share during 2010.
During the first half of 2011 NYSE HSP shares traded above $50 per share and reached in June over $58 per share.
Then on October 18, 2011, Hospira, Inc. (NYSE: HSP) announced certain preliminary third-quarter 2011 results and lowered its FY 2011 EPS Guidance. Among other things, Hospira also said that its adjusted income from operations and adjusted earnings per share are lower than anticipated primarily due to certain quality actions taken in response to a U.S. Food and Drug Administration (FDA) 2010 warning letter and subsequent observations related to the companys manufacturing facility in Rocky Mount, North Carolina, and device quality and supply-related issues.
Shares of Hospira, Inc. (Public, NYSE:HSP) dropped from $37.49 on October 17 to $29.51 on October 18, 2011. In fact, since June 2011 NYSE HSP shares fell from almost $55 per share to as low as $28.67 per share.
